In Type-2 Diabetes Patients with Uncontrolled PPHG
Glimepiride 1 mg + Metformin (SR) 500 mg + Voglibose 0.2 mg Tablets
Glimepiride 2 mg + Metformin (SR) 500 mg + Voglibose 0.2 mg Tablets
The Experts Recommended Combination
- IDF Guidelines suggest that the AGIs could be effective in combination with metformin or sulphonylurea
- A multidimensional approach to control PPG, HbA1c, and GV
- Significantly reduces the fasting glucose levels and HbA1c
- Voglibose is equally effective as sitagliptin at improving endothelial dysfunction in type-2 diabetes patients
